Lucid Diagnostics (LUCD) Property, Plant & Equipment (Net) (2021 - 2026)

Lucid Diagnostics (LUCD) Property, Plant & Equipment (Net) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Abbott Laboratories 183.95 Bn 176.66 Bn 6.27 Bn 12.38 Bn
2 Stryker 128.80 Bn 125.92 Bn 3.81 Bn 3.89 Bn
3 Medtronic 108.82 Bn 99.60 Bn 6.41 Bn 7.42 Bn
4 Boston Scientific 68.54 Bn 67.08 Bn 3.61 Bn 4.06 Bn
5 Edwards Lifesciences 48.37 Bn 44.70 Bn 1.29 Bn 1.82 Bn
6 Dexcom 28.41 Bn 27.30 Bn 750.30 Mn 1.56 Bn
7 GE HealthCare Technologies 28.33 Bn 26.04 Bn 1.98 Bn 3.10 Bn
8 Smith & Nephew 26.96 Bn 26.38 Bn - 6.35 Bn
9 Koninklijke Philips 25.43 Bn 22.31 Bn 2.07 Bn 2.55 Bn
10 Lucid Diagnostics 127.73 Mn 99.85 Mn -325,000.00 907,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 907,000.00
Mar 31, 2026 907,000.00
Dec 31, 2025 809,000.00
Dec 31, 2025 809,000.00
Sep 30, 2025 862,000.00
Sep 30, 2025 862,000.00
Jun 30, 2025 948,000.00
Jun 30, 2025 948,000.00
Mar 31, 2025 1.04 Mn
Mar 31, 2025 1.04 Mn
Dec 31, 2024 1.06 Mn
Dec 31, 2024 1.06 Mn
Sep 30, 2024 940,000.00
Sep 30, 2024 940,000.00
Jun 30, 2024 1.05 Mn
Jun 30, 2024 1.05 Mn
Mar 31, 2024 1.24 Mn
Mar 31, 2024 1.24 Mn
Dec 31, 2023 1.33 Mn
Dec 31, 2023 1.33 Mn